← Back to patent-cliff list
CAS 1403891-71-3
4-(((benzyloxy)carbonyl)amino)-3,5-dimethylbenzenediazonium tetrafluoroborate
Codes: RILP-011
Application context (from source-drug indications)
HIV infectionRilpivirine HydrochlorideHepatic function declineRilpivirine HydrochlorideAcquired immunodeficiency syndromeRilpivirine HydrochlorideContraceptive useRilpivirine Hydrochloride
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Rilpivirine Hydrochloride | Tier B — Position early | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
4-((4-chloropyrimidin-2-yl)amino)benzonitrile→2,6-dimethyl-4-nitroaniline→benzyl (2,6-dimethyl-4-nitrophenyl)carbamate→benzyl (4-amino-2,6-dimethylphenyl)carbamate hydrochloride→4-(((benzyloxy)carbonyl)amino)-3,5-dimethylbenzenediazonium tetrafluoroborate→benzyl (E)-(4-(2-cyanovinyl)-2,6-dimethylphenyl)carbamate→(E)-3-(4-amino-3,5-dimethylphenyl)acrylonitrile hydrochloride
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.